episode-header-image

Aug 2024

6m 25s

Intel dives on weak results, guidance

About this episode

Up next

Oil futures surge on strikes

U.S. strikes Iran, oil (CL1:COM) responds. (00:14) Oklahoma targets Allstate's (ALL) claims practices. (01:27) Streaming's biggest players are chasing the World Cup. (02:14)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers Wednesday: FCEL, BABA, and morePr ... Show More

STAAR prelims signal upside

STAAR Surgical (STAA) announces preliminary net sales for first quarter 2026. (00:14) Disney (DIS) plans 1,000 job cuts in marketing overhaul under new CEO Josh D’Amaro. (01:15) Cheap semaglutide copies in India challenge Novo Nordisk, cut Eli Lilly’s lead: report. (02:07)Episode ... Show More

Insurers pop on Medicare rate hike

Insurance stocks jump on Medicare Advantage rate boost: Humana (HUM), UnitedHealth (UNH), lead gains. (00:14) SpaceX (SPACE) details IPO schedule; retail demand expected to break records - report. (01:00) Amazon (AMZN) reduces its reliance on USPS as expected. (02:33)Episode tran ... Show More

Recommended Episodes

Intel "Stumbles", Inflation Eases, AmEx Rallies and Chevron Posts Record Profit 1/27/23

Carl Quintanilla and Jim Cramer focused on shares of Intel tumbling after the chipmaker posted fourth-quarter results that missed expectations -- and warned of a loss in Q1. The anchors reacted to CEO Pat Gelsinger's earnings call comment: "We realize that we stumbled." The Fed's ... Show More

Intel in slide: a chipmaker on the ropes

<p>Layoffs, suspended dividends, a share price in free fall, a chief executive hustled out the door: Intel is in <a href="https://www.economist.com/business/2024/12/02/intels-troubles-deepen-as-its-boss-makes-an-abrupt-exit?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source ... Show More

Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure

<p>Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coro ... Show More

Big Tech Reports… And Eli Lilly’s Letdown 10/30/24

<p>Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashes guidance. So are the disappointing results a sign th ... Show More

Lululemon Tumbles, Broadcom Surges, Lennar on Eco Data

On this episode of Stock Movers:- Lululemon (LULU) shares tumble after the company slashed its outlook due to weakening demand and the Trump administration's tougher trade policies. The retailer warned it will take a $240 million hit from President Donald Trump's decision to end ... Show More

Intel in slide: a chipmaker on the ropes

Layoffs, suspended dividends, a share price in free fall, a chief executive hustled out the door: Intel is in a bad way. But America needs a chipmaking champion, so what will save it? We examine a legally pioneering International Criminal Court case alleging cross-border crimes a ... Show More